72 related articles for article (PubMed ID: 38722372)
1. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
[TBL] [Abstract][Full Text] [Related]
2. LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.
Gao D; Guo H; Liu Z; Bao L; Li S; Wang Y; Qiu J; Jiang B; Dang X
Curr Cancer Drug Targets; 2024 May; ():. PubMed ID: 38778606
[TBL] [Abstract][Full Text] [Related]
3. RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma.
You K; Du X; Zhao Y; Wen F; Lu Z; Fan H
J Cancer Res Clin Oncol; 2024 May; 150(5):245. PubMed ID: 38722372
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity" [Cancer Lett., 548, (1 November 2022)].
Xu M; Liu Y; Wan HL; Wong AM; Ding X; You W; Lo WS; Ng KK; Wong N
Cancer Lett; 2024 Feb; 583():216601. PubMed ID: 38161138
[No Abstract] [Full Text] [Related]
5. Designing the stripe-ordered cuprate phase diagram through uniaxial-stress.
Guguchia Z; Das D; Simutis G; Adachi T; Küspert J; Kitajima N; Elender M; Grinenko V; Ivashko O; Zimmermann MV; Müller M; Mielke C; Hotz F; Mudry C; Baines C; Bartkowiak M; Shiroka T; Koike Y; Amato A; Hicks CW; Gu GD; Tranquada JM; Klauss HH; Chang JJ; Janoschek M; Luetkens H
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2303423120. PubMed ID: 38150501
[TBL] [Abstract][Full Text] [Related]
6.
Lu W; Zhou S; Ma X; Xu N; Liu D; Zhang K; Zheng Y; Wu S
Microbiol Spectr; 2024 Feb; 12(2):e0254223. PubMed ID: 38149860
[TBL] [Abstract][Full Text] [Related]
7. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
[TBL] [Abstract][Full Text] [Related]
8. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.
Gu Z; Wang L; Dong Q; Xu K; Ye J; Shao X; Yang S; Lu C; Chang C; Hou Y; Zhai Y; Wang X; He F; Sun A
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2215744120. PubMed ID: 37428911
[TBL] [Abstract][Full Text] [Related]
9. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
[TBL] [Abstract][Full Text] [Related]
10. Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis.
Yan M; Guo X; Ji G; Huang R; Huang D; Li Z; Zhang D; Chen S; Cao R; Yang X; Wu W
Front Immunol; 2022; 13():1097853. PubMed ID: 36936475
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.
Liu Z; Zhang X; Zhang H; Zhang H; Yi Z; Zhang Q; Liu Q; Liu X
Microbiol Spectr; 2023 Feb; 11(2):e0503822. PubMed ID: 36786568
[TBL] [Abstract][Full Text] [Related]
12. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities.
da Fonseca LG; Araujo RLC
World J Gastroenterol; 2022 Jul; 28(28):3573-3585. PubMed ID: 36161045
[TBL] [Abstract][Full Text] [Related]
13. HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression.
Hu X; Pan H; Zhou S; Pang Q; Wang Y; Zhu C; Liu H; Jin H; Xu A
Biochem Biophys Res Commun; 2022 Oct; 623():111-119. PubMed ID: 35921704
[TBL] [Abstract][Full Text] [Related]
14. The molecular biology and therapeutic potential of Nrf2 in leukemia.
Khodakarami A; Adibfar S; Karpisheh V; Abolhasani S; Jalali P; Mohammadi H; Gholizadeh Navashenaq J; Hojjat-Farsangi M; Jadidi-Niaragh F
Cancer Cell Int; 2022 Jul; 22(1):241. PubMed ID: 35906617
[TBL] [Abstract][Full Text] [Related]
15. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
16. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
Johnson P; Zhou Q; Dao DY; Lo YMD
Nat Rev Gastroenterol Hepatol; 2022 Oct; 19(10):670-681. PubMed ID: 35676420
[TBL] [Abstract][Full Text] [Related]
17. The role of Th17 cells in the pathogenesis and treatment of breast cancer.
Karpisheh V; Ahmadi M; Abbaszadeh-Goudarzi K; Mohammadpour Saray M; Barshidi A; Mohammadi H; Yousefi M; Jadidi-Niaragh F
Cancer Cell Int; 2022 Mar; 22(1):108. PubMed ID: 35248028
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune subtypes of Ph-neg B-ALL with ferroptosis related genes and the potential implementation of Sorafenib.
Hong Y; Zhang L; Tian X; Xiang X; Yu Y; Zeng Z; Cao Y; Chen S; Sun A
BMC Cancer; 2021 Dec; 21(1):1331. PubMed ID: 34906116
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
